Callan Family Office
RTO icon

Callan Family Office’s Rentokil RTO Stock Holding History

Callan Family Office’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Sell
14,175
-140
-1% -$4.44K 0.01% 888
2026
Q1 		$451K Sell
14,315
-568
-4% -$17.9K 0.01% 803
2025
Q4 		$438K Buy
+14,883
New +$413K 0.01% 816
2025
Q3 		– Sell
-8,921
Closed -$214K – 932
2025
Q2 		$214K Buy
+8,921
New +$207K 0.01% 878

Other funds holding RTO

Jupiter Topco
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Gates Capital Management
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
River Road Asset Management
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Snyder Capital Management
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Callan Family Office's RTO Position: Q2 2026 in Review

Callan Family Office reduced its Rentokil (RTO) stake by 0.98% in Q2 2026, selling an estimated $4.44K and leaving 14,175 shares worth $406K. The position accounts for 0.01% of the portfolio, ranked #888.

Callan Family Office first reported a position in RTO in Q2 2025 and has held it in 4 quarters since. The position peaked at $451K in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Callan Family Office held 14,175 shares of Rentokil worth $406K as of Q2 2026.
  • Callan Family Office sold 140 Rentokil shares in Q2 2026, an estimated $4.44K.
  • Rentokil made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #888 holding.
  • Callan Family Office first reported a position in Rentokil in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Rentokil position peaked at $451K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.